Immunotherapy for Guillain-Barré syndrome in the us hospitals

Journal of Clinical Neuromuscular Disease

Volumn 10, Issue 1, 2008, Pages 4-10

  Alshekhlee, Amer ^a   Hussain, Zulfiqar ^a   Sultan, Badr ^a   Katirji, Bashar ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

GuillainBarr ; Immunoglobulin; Plasmapheresis; Syndrome

Indexed keywords

IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; ARTICLE; BACTEREMIA; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; ENDOTRACHEAL INTUBATION; FEMALE; GUILLAIN BARRE SYNDROME; HEART ARREST; HEART ARRHYTHMIA; HOSPITAL; HOSPITAL DISCHARGE; HOSPITAL UTILIZATION; HOSPITALIZATION; HUMAN; IMMUNOTHERAPY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLASMAPHERESIS; PRIORITY JOURNAL; RESPIRATORY ARREST; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; SEPSIS; SEPTICEMIA; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNITED STATES; VEIN THROMBOSIS; AGED; COHORT ANALYSIS; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NONPARAMETRIC TEST; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME; UTILIZATION REVIEW;

ADULT; AGED; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; GUILLAIN-BARRE SYNDROME; HOSPITALS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY; LOGISTIC MODELS; MALE; MIDDLE AGED; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 63849101167     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e318182b5ce     Document Type: Article

References (14)

1. Brettle RP, Gross M, Legg NJ, et al. Treatment of acute polyneuropathy by plasma exchange. Lancet. 1978;2:1100.
2. Kleyweg RP, van der Meché FGA, Meulstee J. Treatment of Guillain-Barré syndrome with high dose gammaglobulin. Neurology. 1988;38:1639-1642.
3. The Guillain-Barré Syndrome Study Group. Plasma-pheresis and acute Guillain-Barré syndrome. Neurology. 1985;35:1096-1104.
4. Van der Meché FGA, Schmitz PIM, the Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med. 1992;326:1123-1129.
5. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Plasma exchange in Guillain-Barré syndrome: one-year follow-up. Ann Neurol. 1992;32:94-97.
6. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet. 1997;349:225-230.
7. Alshekhlee A, Hussain Z, Sultan B, et al. Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Neurology. 2008;70:1608-1613.
8. Dubinsky R, Lai SM. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample. Neurology. 2006;66:1742-1744.
9. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
10. Lawn ND, Wijdicks EF. Fatal Guillain-Barré syndrome. Neurology. 1999;52:635-638.
11. Fletcher DD, Lawn ND, Wolter TD, et al. Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. Neurology. 2000;54:2311-2315.
12. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann Neurol. 1987;22:753-761.
13. Hughes RA, Swan AV, Raphael JC, et al. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain. 2007;130:2245-2257.
14. Hughes RA, Wijdicks EF, Barohn R, et al. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003;61:736-740.